Paul Sekhri
InvestorExecutive Partner at Syncona
About
Paul Sekhri is an Executive Partner of Syncona Investment Management Limited with over 40 years of experience across the life sciences industry, including operating roles at pharmaceutical companies, biotech firms, and venture capital and private equity organisations. He previously served as President and CEO of eGenesis and Lycera Corporation, and held senior roles at Sanofi, Teva Pharmaceutical Industries, TPG Biotech, ARIAD Pharmaceuticals, and Novartis. He founded and led Cerimon Pharmaceuticals and has served on more than 40 public and private company boards.
Invests in
Biotech
Deals · 1
Pronutria BiosciencesBoard seat
via Syncona · filed Sep 2022 · $12M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Deep GenomicsKayotheraResolution TherapeuticsVeeva SystemsViolet TherapeuticsvTv Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Syncona
Frequently asked questions
- Who is Paul Sekhri?
- Paul Sekhri is an Executive Partner of Syncona Investment Management Limited with over 40 years of experience across the life sciences industry, including operating roles at pharmaceutical companies, biotech firms, and venture capital and private equity organisations. He previously served as President and CEO of eGenesis and Lycera Corporation, and held senior roles at Sanofi, Teva Pharmaceutical Industries, TPG Biotech, ARIAD Pharmaceuticals, and Novartis. He founded and led Cerimon Pharmaceuticals and has served on more than 40 public and private company boards.
- Where does Paul Sekhri work?
- Paul Sekhri is Executive Partner at Syncona.
- What does Paul Sekhri invest in?
- Paul Sekhri invests in Biotech.
- What boards does Paul Sekhri sit on?
- Paul Sekhri holds tracked board seats at Deep Genomics, Kayothera, Pronutria Biosciences, Resolution Therapeutics, Veeva Systems, Violet Therapeutics, vTv Therapeutics.